EXHIBIT 11. STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE
(Unaudited)
Eli Lilly and Company and Subsidiaries
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
(Dollars and shares in millions except per- | ||||||||||||||||
share data) | ||||||||||||||||
BASIC | ||||||||||||||||
Net income | $ | 663.6 | $ | 822.0 | $ | 1,172.3 | $ | 1,656.8 | ||||||||
Average number of common shares outstanding | 1,089.0 | 1,084.7 | 1,088.7 | 1,084.9 | ||||||||||||
Contingently issuable shares | .6 | — | 1.0 | .5 | ||||||||||||
Adjusted average shares | 1,089.6 | 1,084.7 | 1,089.7 | 1,085.4 | ||||||||||||
Basic earnings per share | $ | .61 | $ | .76 | $ | 1.08 | $ | 1.53 | ||||||||
DILUTED | ||||||||||||||||
Net income | $ | 663.6 | $ | 822.0 | $ | 1,172.3 | $ | 1,656.8 | ||||||||
Average number of common shares outstanding | 1,089.0 | 1,084.7 | 1,088.7 | 1,084.9 | ||||||||||||
Incremental shares — stock options and contingently issuable shares | .9 | .6 | 1.2 | 1.3 | ||||||||||||
Adjusted average shares | 1,089.9 | 1,085.3 | 1,089.9 | 1,086.2 | ||||||||||||
Diluted earnings per share | $ | .61 | $ | .76 | $ | 1.08 | $ | 1.53 | ||||||||
Dollars and shares in millions except per-share data.